Core Viewpoint - The stock of Giant Bio (02367) experienced a significant decline of 15% during trading, with a current drop of 11.8%, trading at HKD 54.2, and a transaction volume of HKD 1.716 billion. This decline is linked to allegations regarding the quality of its collagen products, which have raised concerns about potential false advertising [1]. Group 1: Company Response and Actions - Huaxi Biological has officially responded to the situation involving Dr. Hao Yu, stating that after receiving his request for assistance, it collaborated with multiple third-party testing organizations to assess the relevant products, revealing that the recombinant collagen content did not meet standards in several test results [1]. - Huaxi Biological has submitted dozens of test reports to the National Medical Products Administration, indicating a proactive approach to addressing the allegations [1]. Group 2: Allegations and Product Quality Issues - On May 24, beauty blogger Dr. Hao Yu published a report claiming that the collagen content in Giant Bio's "Collagen Stick" was only 0.0177%, significantly below the advertised standard, and that a key amino acid, glycine, was "not detected," raising suspicions of false advertising [1]. - Giant Bio quickly denied these claims, asserting that their products comply with regulations and that internal testing results exceed 0.1% [1]. - Following a series of exchanges, on June 23, Giant Bio acknowledged that its existing quality standards, testing methods, and labeling have shown limitations in certain aspects [1].

Core Viewpoint - The stock of Giant Bio (02367) experienced a significant decline of 15% during trading, with a current drop of 11.8%, trading at HKD 54.2, and a transaction volume of HKD 1.716 billion [1] Group 1: Company Response and Actions - Huaxi Bio has officially responded to the controversy surrounding Dr. Hao Yu, stating that it has collaborated with multiple third-party testing organizations to assess related products, revealing that the recombinant collagen protein content did not meet standards in several test results [1] - Huaxi Bio has submitted dozens of test reports to the National Medical Products Administration [1] - Giant Bio quickly denied the allegations, asserting that its product complies with standards and that internal testing results exceed 0.1% [1] Group 2: Controversy and Public Reactions - On May 24, beauty blogger Dr. Hao Yu released a test report claiming that the actual recombinant collagen protein content in Giant Bio's "Collagen Stick" was only 0.0177%, significantly lower than advertised, and that the key amino acid glycine was "not detected," raising concerns of false advertising [1] - Following the initial claims, Giant Bio received an apology from the testing organization used by Dr. Hao Yu, stating that it had "never authorized Dr. Hao to use the report" [1] - On June 23, Giant Bio acknowledged that its "existing quality standards, testing methods, and labeling have gradually shown limitations in certain aspects" [1]

Core Viewpoint - The stock of Giant Bio (02367) experienced a significant decline of 15% during trading, with a current drop of 11.8%, trading at HKD 54.2, and a transaction volume of HKD 1.716 billion. This decline is linked to allegations regarding the quality of its collagen products, which have raised concerns about potential false advertising [1]. Group 1: Company Response and Actions - Huaxi Biological has officially responded to the situation involving Dr. Hao Yu, stating that after receiving his request for assistance, it collaborated with multiple third-party testing organizations to conduct tests on related products, revealing that the recombinant collagen content did not meet standards [1]. - Huaxi Biological has submitted dozens of test reports to the National Medical Products Administration, indicating a proactive approach to address the allegations [1]. Group 2: Allegations and Product Quality Issues - On May 24, beauty blogger Dr. Hao Yu released a report claiming that the actual recombinant collagen content in Giant Bio's "Collagen Stick" was only 0.0177%, significantly lower than advertised, and that a key amino acid, glycine, was "not detected," raising suspicions of false advertising [1]. - Giant Bio quickly denied these claims, asserting that its products comply with regulations and that internal testing showed results exceeding 0.1% [1]. - On June 23, Giant Bio acknowledged that its existing quality standards, testing methods, and labeling have shown limitations in certain aspects, indicating a recognition of potential issues within its product quality assurance processes [1].

Core Viewpoint - Valentino Beauty announced the cessation of its operations in Taiwan by December 31, 2025, after entering the market only in July 2023, indicating potential challenges in the competitive beauty market [2][5]. Company Summary - Valentino Beauty, a high-end beauty line under the Italian luxury brand Valentino, is globally operated by L'Oréal Group [5]. - The brand will stop recruiting new members and upgrading membership levels starting September 1, 2025, while the points redemption service will continue until February 28, 2026 [2]. Industry Summary - The beauty market in Taiwan has become increasingly competitive, with brands facing significant operational pressures due to changing consumer demands and habits [5]. - The overall beauty market growth has slowed, with retail sales for cosmetics reaching 229.1 billion yuan, a year-on-year increase of only 2.9% in the first half of the year [7]. - Many beauty brands are opting to exit markets or streamline their brand portfolios in response to intense competition [7][8].

Core Viewpoint - Revlon's brand Almay is facing a class-action lawsuit for allegedly false advertising its makeup wipes as "100% biodegradable" [2][4] Company Summary - Revlon, a well-known international cosmetics company, has faced significant operational challenges in recent years, including exiting the Chinese market in January 2014, resulting in the closure of stores and the layoff of 1,100 employees [5] - From 2017 to 2021, Revlon reported continuous net losses, leading to a substantial debt burden [5] - In June 2022, Revlon filed for bankruptcy protection with total debts reaching $3.7 billion, but successfully emerged from bankruptcy in 2023, reducing its debt by $2.7 billion [5] Management Changes - Following its bankruptcy, Revlon initiated a major leadership overhaul, appointing new executives including a CEO, CFO, North America President, and Chief Strategy and Transformation Officer [6] Industry Context - The entire beauty market is currently facing challenges, not just Revlon, as competition intensifies and market pressures increase [6]

Core Viewpoint - The stock of Giant Bio (02367) has dropped over 4%, currently trading at 58.9 HKD with a transaction volume of 272 million HKD, following allegations regarding the quality of its collagen products [1] Group 1: Company Response and Allegations - Huaxi Bio has officially responded to the allegations surrounding Dr. Hao Yu, stating that it has conducted tests with multiple third-party institutions, revealing that the recombinant collagen content in related products did not meet standards [1] - Huaxi Bio has submitted dozens of test reports to the National Medical Products Administration, indicating a serious approach to addressing the quality concerns raised [1] - The controversy began in May when beauty blogger Dr. Hao Yu accused Giant Bio's product "Collagen Stick" of having a recombinant collagen content of only 0.0177%, significantly below the 0.1% non-trace addition standard [1] Group 2: Ongoing Disputes and Company Statements - Giant Bio quickly denied the allegations, asserting that its products comply with regulations and that internal testing results exceed the 0.1% standard [1] - On June 1, Huaxi Bio publicly supported Dr. Hao Yu, intensifying the conflict between the two parties [1] - Following a series of exchanges, Giant Bio acknowledged on June 23 that its existing quality standards, testing methods, and labeling have shown limitations in certain aspects [1]

Core Viewpoint - The stock of Giant Bio (02367) has dropped over 4%, currently trading at 58.9 HKD with a transaction volume of 272 million HKD, following allegations regarding the quality of its collagen products [1] Group 1: Company Developments - Huaxi Bio has officially responded to the controversy surrounding Dr. Hao Yu, revealing that it has conducted tests on related products in collaboration with multiple third-party testing agencies, which indicated that the recombinant collagen content did not meet standards [1] - Huaxi Bio has submitted dozens of test reports to the National Medical Products Administration, highlighting the seriousness of the findings [1] - In May, beauty blogger Dr. Hao Yu accused Giant Bio's product "Collagen Stick" of having a recombinant collagen content of only 0.0177%, significantly below the 0.1% non-trace addition standard, and lacking the core amino acid glycine [1] Group 2: Company Responses - Giant Bio quickly denied the allegations, asserting that its products comply with regulations and that internal testing results exceed the 0.1% standard [1] - On June 1, Huaxi Bio publicly supported Dr. Hao Yu, indicating a division in the industry regarding the quality of Giant Bio's products [1] - Following a series of exchanges, on June 23, Giant Bio acknowledged that its existing quality standards, testing methods, and labeling have shown limitations in certain aspects [1]

Emerging Markets Dynamics - Russia plans to launch a digital ruble roadmap with a large-scale rollout set for September 1, 2026, and initial pilot projects starting on October 1, 2025 [1] - The UAE's new economic cluster policy aims to enhance industrial competitiveness and expand global market access, contributing over 30 billion dirhams annually to GDP and increasing foreign trade by 15 billion dirhams over the next seven years [1] Financial Cooperation - Brazil and China are accelerating the use of local currencies in bilateral trade and financial investments, with a focus on reducing transaction costs and currency risks, and have approved $2.8 billion for environmental projects [2] - Brazil's government is investing 3.4 million reais to promote e-commerce development in regions outside the southeast, with a projected annual growth rate exceeding 10% by 2029 [2] Tax Incentives - Laos has implemented a VAT exemption policy for certain export goods, including minerals and electricity, to attract investment and enhance competitiveness in international markets [2] Platform Dynamics - Temu has significantly reduced prices in the U.S. market, with an average decrease of 18% for 24 popular items since April, as part of its strategy to regain market share [3][4] - Ozon plans to increase sales commissions for sellers using its official fulfillment model starting September 25, 2025, with an average increase of 1.75% across most categories [4] - Amazon's Prime Big Deal Days are scheduled for October 7-8, 2025, marking the start of the holiday shopping season [5] - Amazon, Temu, and Shein have seen significant user growth in Australia, with Temu's sales increasing from 1.6 billion to 2.6 billion AUD [6] - Temu's UK revenue for FY2024 reached approximately $63.3 million, nearly doubling from the previous year, despite operational losses [6] E-commerce Market Trends - AliExpress remains the largest Chinese e-commerce platform in Europe, with an average of 190 million users from February to July [7] - Trendyol aims for $6 billion in exports by 2028, while Noon is enhancing its financial services and logistics capabilities [8] Policy Developments - Mexico, the U.S., and Canada have agreed to continue executing the USMCA, with a public consultation process for its first revision starting [19] - The Philippines has mandated that all e-commerce businesses obtain a government-issued Trustmark by September 30, 2025, to ensure compliance with national standards [19]

Investment Rating - The report initiates coverage on the company with a "Buy" rating [6][27]. Core Insights - The company is a pioneer in luxury fragrance management in China, having introduced high-end perfumes systematically since 1980. It operates through a brand authorization model, providing comprehensive services from market access to consumer education [6][10]. - The Chinese perfume market is projected to be the fastest-growing segment in the cosmetics industry, with a compound annual growth rate (CAGR) of 9-14% over the next 4-5 years. The company is positioned as a key beneficiary of this growth, with 81% of its revenue derived from fragrance sales [6][10][15]. - The company has a strong market presence, ranking third in market share in China (including Hong Kong and Macau) with 9.3% [9][11]. Financial Overview - The company’s projected financials indicate a steady increase in sales revenue from RMB 1,864 million in FY24A to RMB 3,134 million in FY28E, reflecting a CAGR of 15% [6][8]. - Net profit is expected to grow from RMB 206.5 million in FY24A to RMB 370.3 million in FY28E, with a notable increase of 32% in FY26E [6][8]. - The target price is set at HKD 3.49, representing a potential upside of 72.8% from the current price of HKD 2.02 [2][6]. Market Dynamics - The report highlights the increasing penetration of perfumes in China, with per capita spending on perfumes significantly lower than in developed markets. In 2023, the per capita spending in China was RMB 16 compared to RMB 423 in the US [15][17]. - The growth in the perfume market is supported by rising consumer demand in lower-tier cities and a significant increase in male fragrance spending, which saw a 1151% year-on-year growth in 2023 [18][19]. Business Model and Strategy - The company operates a multi-brand strategy, managing over 70 international brands and providing a wide range of products across various price points, which enhances its negotiation power with distribution channels [22][25]. - The company has established a robust supply chain and distribution network, covering 400 cities and 7,800 sales terminals, which allows for precise matching of brands to sales channels [24][25]. Competitive Landscape - The company faces competition from both international luxury brands and emerging domestic brands. However, the report suggests that the threat from domestic brands is currently limited as they primarily serve to cultivate potential customers for high-end brands [27]. - The company has long-term contracts with key suppliers, reducing the risk of losing core brand operating rights, which is a concern among investors [27].

Core Viewpoint - The outdoor brand Arc'teryx faced significant backlash for hosting a large-scale fireworks show in the environmentally sensitive Himalayan region, raising questions about the brand's commitment to nature and sustainability [3][4][6]. Group 1: Event Overview - The fireworks event, a collaboration between Arc'teryx and artist Cai Guoqiang, was intended to elevate the brand's artistic spirit but resulted in widespread criticism regarding environmental impact [3][4]. - Following the event, both Arc'teryx and Cai Guoqiang issued apologies, and the incident prompted official investigations, leading to a significant drop in the market value of related company Anta Sports, which lost 7.7 billion in market capitalization [4][10]. Group 2: Environmental Concerns - The Himalayan ecosystem is fragile, with slow soil recovery and sensitivity to noise and chemical pollutants, making the fireworks display particularly damaging [7][9]. - Despite claims of using eco-friendly materials and obtaining necessary approvals, public skepticism remained regarding the effectiveness and scientific evaluation of these measures [9][10]. Group 3: Brand Image and Public Expectations - Arc'teryx's actions contradicted its established brand values of high performance and respect for nature, leading to public outrage over perceived hypocrisy [10][11]. - The incident highlighted the growing public expectation for brands to act as responsible citizens, not just providers of products and services [6][10]. Group 4: Lessons for Other Brands - The event serves as a cautionary tale for beauty brands, emphasizing the importance of aligning brand values with actual practices and avoiding actions that could harm the environment [11][12]. - Brands should carefully consider the potential offensive nature of their marketing strategies and ensure that public discussions around their actions are constructive rather than damaging [12][13]. - Effective crisis response is crucial, with brands needing to develop comprehensive plans that include sincere apologies and transparent action plans following any missteps [13][14]. Group 5: Sustainable Practices in the Industry - Companies like Naturals have successfully integrated sustainability into their business models, demonstrating long-term commitment to environmental stewardship through initiatives like the "Himalayan Environmental Protection Fund" [16][19]. - Other brands, such as L'Oréal and L'Occitane, have implemented sustainable practices across their operations, focusing on biodiversity and environmental impact assessments [22][23].